IRCT - Iranian Registry of Clinical Trials

Welcome to Iranian Registry of Clinical Trials. This is a WHO Primary Register set up with the help from the Ministry of Health and Medical Education.

The three main objectives of this site are:
Informing public of the ongoing trials
Increasing public awareness of their importance
Implementing the International Committee of Medical Journal Editors initiative for mandatory registration of trials before the enrollment of the first patient.

According to the international committee of medical journal Editors (ICMJE) any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.

Interventions include but are not restricted to drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioural treatments, process-of-care changes, preventive care, etc.

You need to take the following steps:

You need to register with IRCT web-site and set up an account
IRCT staff will get back to you when the information you have provided has been verified and accepted.
You can proceed if you are eligible to do so. Chief investigator or representatives of the sponsor are among people who can register a trial.
You then need to enter all the required information
The information will be verified by IRCT staff. When all information is complete, you will be given your registration ID with IRCT.
You then need to keep your trial record up to date by updating your trials when any of the characteristics of your trial such as design or timings have changed

In a medical breakthrough, scientists have discovered the structure of the AIDS virus, which may lead to more effective treatments in this field.

Tue, 02 Feb 2010 15:37:59 GMT
British and American researchers have grown a new crystal which enables them to study the three-dimensional structure of integrase, an enzyme found in retroviruses such as HIV.

According to a study published in Nature, the crystal enables scientists to see for the first time how the medicines bind to and block integrase.

Integrase, the enzyme which pastes a copy of the genetic information of the HIV virus into the victim's DNA, is the target for the newest HIV medicines known as integrase inhibitors (Isentress, elvitegravir).

Scientists hope their findings will pave the way for the development of new treatments to fight HIV.

Latest figures revealed that 33.4 million individuals including 2 million deaths have been affected with HIV/AIDS. Sub-Saharan Africa is reported the worst region hit by the virus, accounting for 67 percent of HIV-positive cases.

resstv

IRCT is a not for profit website
Search within the content of this website is allowed for members of public
All researchers can register their trials in this site from all over the world
All content of this site after verification is in public domain without charge
There are mechanisms to check for validity of registered information

Scientific steering committee:

A committee of distinguished researchers and country’s top medical journal editors oversee IRCT activities

In line with previous studies, a new study finds taking one fish oil capsule every day can prevent mental illnesses in the at-risk population.
presstv
Tue, 02 Feb 2010 15:38:02 GMT